Physician profile
James M Barry
NPI 1952304743
$91,284.75
in general payments reported to CMS, 2019-2025
88 companies · $5,064 in 2025
The $5,064 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $11K · 2021: $15K · 2022: $13K · 2023: $5,052 · 2024: $4,693 · 2025: $5,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,651.44 |
| Education | $158.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $25,872.62 | 2019-2025 | |
| Biogen, INC. | $17,915.07 | 2019-2025 | Tysabri, Vumerity, Leqembi |
| Genentech USA, INC. | $9,537.32 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Evrysdi |
| Celgene Corporation | $7,168.05 | 2019-2025 | Zeposia |
| Banner Life Sciences, LLC | $3,561.46 | 2021-2023 | |
| Abbvie INC. | $2,832.14 | 2019-2025 | Botox, Duopa, Qulipta |
| Novartis Pharmaceuticals Corporation | $1,904.42 | 2019-2025 | |
| Emd Serono, INC. | $1,710.48 | 2019-2025 | Mavenclad |
| Teva Pharmaceuticals USA, INC. | $1,633.82 | 2019-2025 | Austedo Xr, Austedo Xr |
| Grifols USA, LLC | $1,371.05 | 2019-2025 | Gamunex-C, Xembify |
| Acadia Pharmaceuticals INC | $1,143.64 | 2019-2025 | Nuplazid |
| Ucb, INC. | $1,022.59 | 2019-2025 | Briviact, Rystiggo |
| Amgen INC. | $933.79 | 2019-2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $893.78 | 2019-2025 | Ultomiris, Soliris |
| Allergan, INC. | $771.11 | 2019-2022 |
Show all 87 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tg Therapeutics, INC. | $653.21 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $629.95 | 2019-2025 | Ingrezza, Ongentys |
| Csl Behring | $609.85 | 2019-2025 | Hizentra |
| Pfizer INC. | $608.17 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $604.12 | 2019-2025 | Crexont, Rytary, Ongentys 50mg Capsules 30 |
| Lilly USA, LLC | $581.48 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Sk Life Science, INC. | $499.27 | 2020-2025 | |
| Alnylam Pharmaceuticals INC. | $470.86 | 2019-2025 | Onpattro |
| Eisai INC. | $411.35 | 2020-2025 | |
| Merz Pharmaceuticals, LLC | $398.95 | 2021-2024 | Xeomin |
| Tanabe Pharma America, INC. | $359.00 | 2019-2025 | Radicava |
| Horizon Therapeutics Plc | $335.79 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $307.94 | 2022 | |
| Jazz Pharmaceuticals INC. | $303.35 | 2019-2024 | Xywav |
| Janssen Pharmaceuticals, INC | $296.71 | 2021-2022 | |
| Mdd US Operations, LLC | $283.48 | 2019-2025 | Gocovri, Gocovri |
| Argenx US, INC. | $281.08 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Ge Healthcare | $280.04 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $275.21 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $263.66 | 2020-2021 | |
| Lundbeck LLC | $238.79 | 2019-2022 | |
| Impel Pharmaceuticals INC. | $237.16 | 2022-2023 | Trudhesa |
| Vanda Pharmaceuticals INC. | $219.08 | 2024-2025 | Ponvory |
| Boston Scientific Corporation | $216.15 | 2019-2025 | Vercise, Wavewriter Alpha Prime 16 |
| Upsher-Smith Laboratories LLC | $212.93 | 2019-2022 | |
| Kyowa Kirin, INC. | $211.43 | 2020-2022 | |
| Acorda Therapeutics, INC | $210.88 | 2019-2023 | Inbrija, Ampyra |
| Merz North America, INC. | $205.28 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $199.70 | 2022-2024 | Dysport |
| Ani Pharmaceuticals, INC. | $189.59 | 2022-2024 | Purified Cortrophin Gel |
| Scilex Pharmaceuticals INC. | $171.38 | 2022-2023 | Ztlido |
| Harmony Biosciences LLC | $158.38 | 2020-2024 | |
| Octapharma USA, INC. | $156.59 | 2022-2024 | Octagam Immune Globulin (Human), Panzyga |
| E.R. Squibb & Sons, L.L.C. | $154.97 | 2020-2025 | Zeposia |
| Adamas Pharmaceuticals, INC. | $154.24 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $139.34 | 2019-2025 | Qelbree |
| Mallinckrodt Enterprises LLC | $126.77 | 2019 | |
| Avanir Pharmaceuticals, INC. | $101.13 | 2019-2022 | |
| Revance Therapeutics, INC. | $99.85 | 2024 | Daxxify |
| Axsome Therapeutics, INC. | $85.55 | 2023-2025 | Sunosi, Symbravo |
| Takeda Pharmaceuticals U.S.A., INC. | $82.38 | 2022-2023 | Gammagard |
| Amylyx Pharmaceuticals, INC. | $80.92 | 2023 | Relyvrio |
| Mallinckrodt Hospital Products INC. | $74.96 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $58.31 | 2019-2022 | |
| Azurity Pharmaceuticals, INC. | $57.94 | 2023-2025 | Horizant, Horizant |
| Bausch Health US, LLC | $55.77 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $49.72 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $48.59 | 2021-2025 | Bevespi Aerosphere |
| Assertio Therapeutics, INC. | $42.02 | 2020 | |
| Sumitomo Pharma America, INC. | $36.67 | 2023 | Aptiom |
| Otsuka America Pharmaceutical, INC. | $33.20 | 2024 | Nuedexta |
| Aprecia Pharmaceuticals, LLC | $33.17 | 2020-2022 | |
| Nevro Corp. | $33.13 | 2023 | Senza |
| Avion Pharmaceuticals | $31.37 | 2022 | |
| Currax Pharmaceuticals LLC | $24.83 | 2020-2021 | |
| Amicus Therapeutics, INC. | $24.79 | 2025 | |
| Greenwich Biosciences, INC. | $24.12 | 2021 | |
| Noctrix Health, INC. | $22.01 | 2025 | Nidra |
| Ns Pharma, INC. | $22.00 | 2025 | Viltepso |
| Promius Pharma LLC | $21.18 | 2019 | |
| Invivyd INC | $21.13 | 2025 | Pemgarda |
| Tersera Therapeutics LLC | $19.80 | 2025 | Quzyttir |
| Collegium Pharmaceutical, INC. | $19.57 | 2022 | |
| Stryker Corporation | $19.53 | 2022 | |
| 3b Medical, INC. | $19.51 | 2025 | Luna |
| Cycle Pharmaceuticals INC | $17.80 | 2025 | Ormalvi |
| Almatica Pharma LLC | $17.47 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $16.77 | 2023 | |
| Vertical Pharmaceuticals, LLC | $16.32 | 2019 | |
| Sandoz INC. | $16.05 | 2023 | |
| Livanova USA, INC. | $15.89 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Idorsia Pharmaceuticals US INC | $13.83 | 2023 | Quviviq |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Botox $1,250Leqembi $796Tysabri $700Briumvi $653Kesimpta $557Gamunex-C $541Ingrezza $535Austedo Xr $499Nuplazid $476Vumerity $465Mavenclad $445Ocrevus $375Qulipta $357Nurtec Odt $355Ultomiris $346Ocrevus Zunovo $309Vyalev $301Crexont $297Onpattro $282Kisunla $230Ponvory $219Panzyga $202Octagam Immune Globulin (Human) $194Duopa $191Hizentra $187Ubrelvy $186Zeposia $179Radicava $166Ztlido $156Dysport $146Vyvgart Hytrulo $135Rytary $134Briviact $131Uplizna $131Ongentys $120Trudhesa $112Xeomin $104Daxxify $99.85Radicava Ors $97.91Rystiggo $96.85Gocovri $89.82Vyvgart $85.40Exservan $84.10Relyvrio $80.92Amyvid $72.72Purified Cortrophin Gel $70.57Gammagard $65.72Soliris $62.28Sunosi $59.85Ongentys 50mg Capsules 30 $57.76Nexviazyme $50.82Emgality $47.77Reyvow $47.77Xywav $45.41Horizant $42.53Aptiom $36.67Inbrija $36.41Nuedexta $33.20Senza $33.13Skyclarys $29.23Vercise $27.85Xembify $27.32Epidiolex $27.25Symbravo $25.70Bafiertam $24.61Spinraza $24.33Evrysdi $23.76Nidra $22.01Viltepso $22.00Pemgarda $21.13Quzyttir $19.80Plegridy $19.71Luna $19.51Bevespi Aerosphere $18.77Ormalvi $17.80Ampyra $17.39Qelbree $16.48Vns Therapy Sentiva Model 1000 Generator $15.89Wavewriter Alpha Prime 16 $15.32Quviviq $13.83Wakix $13.67Qalsody $6.49
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Barry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.